首页> 外文期刊>Journal of Cardiovascular Disease Research >Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography
【24h】

Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography

机译:血浆高半胱氨酸水平及其基因型是冠状动脉造影患者冠心病的危险因素

获取原文
获取外文期刊封面目录资料

摘要

Background: Hyperhomocysteinemia has recently been identified as a risk factor for coronary artery disease. Some genetic variants (such as C677T polymorphism) are postulated in this regard. We studied the relation between hyperhomocysteinemia and the above genetic variant and risk of coronary artery disease (CAD) and also the number of involved vessels. Materials and Methods: From a total of 90 patients, 45 showed angiographically documented CAD and 45 had clinical manifestations of CAD but a negative angiography. Blood homocysteine level and C677T polymorphism were evaluated by Enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) respectively. Results: Homocysteine level was significantly higher in the case group (P < 0.001) but no correlation was found between its level and extent of CAD. More homozygote cases of C677T allele were detected in the case group which was not related to the extent of CAD either. Conclusion: Presence of hyperhomocysteinemia increases the risk of CAD but does not predict the extent of it.
机译:背景:高同型半胱氨酸血症最近已被确定为冠状动脉疾病的危险因素。在这方面假定了一些遗传变异(例如C677T多态性)。我们研究了高同型半胱氨酸血症与上述遗传变异和冠状动脉疾病(CAD)风险之间的关系,并研究了受累血管的数量。材料和方法:在总共90例患者中,有45例显示有血管造影记录的CAD,其中45例具有CAD的临床表现,但血管造影结果为阴性。分别通过酶联免疫吸附试验(ELISA)和聚合酶链反应(PCR)评估血同型半胱氨酸水平和C677T多态性。结果:同型半胱氨酸水平在病例组中显着较高(P <0.001),但其水平与CAD程度之间没有相关性。在病例组中检测到更多的C677T等位基因纯合子病例,这与CAD的程度也不相关。结论:高同型半胱氨酸血症的存在会增加CAD的风险,但不能预测其程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号